| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CME | Common Stock Class A | -Sell | -$1,464,046 | -6,583 | -8.41% | $222.40 | 71,704 | Nov 5, 2021 | Direct | F1 |
| transaction | CME | Common Stock Class A | -Sell | -$717,091 | -3,238 | -4.52% | $221.46 | 68,466 | Nov 5, 2021 | Direct | F2 |
| transaction | CME | Common Stock Class A | -Sell | -$39,515 | -179 | -0.26% | $220.76 | 68,287 | Nov 5, 2021 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | On November 5, 2021, Mr. Durkin sold an aggregate of 6,583 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $222.141 to $222.81. The Company maintains a record of the transaction and copies will be provided upon request. |
| F2 | On November 5, 2021, Mr. Durkin sold an aggregate of 3,238 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $221.022 to $221.995. The Company maintains a record of the transaction and copies will be provided upon request. |
| F3 | On November 5, 2021, Mr. Durkin sold an aggregate of 179 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $220.72 to $220.78. The Company maintains a record of the transaction and copies will be provided upon request. |